203 related articles for article (PubMed ID: 1280509)
1. Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria.
Baur M; Hay U; Novacek G; Dittrich C; Ferenci P
Arch Virol Suppl; 1992; 4():76-80. PubMed ID: 1280509
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
[TBL] [Abstract][Full Text] [Related]
3. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C and B viruses, and their association with hepatocellular carcinoma in Egypt.
Darwish MA; Issa SA; Aziz AM; Darwish NM; Soliman AH
J Egypt Public Health Assoc; 1993; 68(1-2):1-9. PubMed ID: 7504048
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and C viral infections in patients with hepatocellular carcinoma.
Ruiz J; Sangro B; Cuende JI; Beloqui O; Riezu-Boj JI; Herrero JI; Prieto J
Hepatology; 1992 Sep; 16(3):637-41. PubMed ID: 1380480
[TBL] [Abstract][Full Text] [Related]
7. Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia.
Bile K; Aden C; Norder H; Magnius L; Lindberg G; Nilsson L
Scand J Infect Dis; 1993; 25(5):559-64. PubMed ID: 7506842
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
9. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.
Kiyosawa K; Sodeyama T; Tanaka E; Gibo Y; Yoshizawa K; Nakano Y; Furuta S; Akahane Y; Nishioka K; Purcell RH
Hepatology; 1990 Oct; 12(4 Pt 1):671-5. PubMed ID: 2170265
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger.
Cenac A; Pedroso ML; Djibo A; Develoux M; Pichoud C; Lamothe F; Trepo C; Warter A
Am J Trop Med Hyg; 1995 Apr; 52(4):293-6. PubMed ID: 7537942
[TBL] [Abstract][Full Text] [Related]
11. Viral pathogenesis of hepatocellular carcinoma in the United States.
Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER
Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
[TBL] [Abstract][Full Text] [Related]
12. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.
Colombo M; Kuo G; Choo QL; Donato MF; Del Ninno E; Tommasini MA; Dioguardi N; Houghton M
Lancet; 1989 Oct; 2(8670):1006-8. PubMed ID: 2572740
[TBL] [Abstract][Full Text] [Related]
14. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
J Med Virol; 1994 Sep; 44(1):92-5. PubMed ID: 7528262
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
17. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH
J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C-associated hepatocellular carcinoma.
Hasan F; Jeffers LJ; De Medina M; Reddy KR; Parker T; Schiff ER; Houghton M; Choo QL; Kuo G
Hepatology; 1990 Sep; 12(3 Pt 1):589-91. PubMed ID: 2169456
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K
Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
